{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "11055218", "DateCompleted": {"Year": "2000", "Month": "12", "Day": "04"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0042-465X", "JournalIssue": {"Volume": "116", "Issue": "2", "PubDate": {"Year": "2000", "Season": "Jan-Feb"}}, "Title": "Vestnik oftalmologii", "ISOAbbreviation": "Vestn Oftalmol"}, "ArticleTitle": "[New prospects in the treatment of intraocular infection].", "Pagination": {"StartPage": "20", "EndPage": "22", "MedlinePgn": "20-2"}, "Abstract": {"AbstractText": ["Clinical trials were carried out on 55 patients (55 eyes) divided into 2 groups. The main group consisted of 27 patients treated by a therapeutic complex including vitrectomy with ozonized normal saline and the controls (28 pts) were treated by vitrectomy with intravitreal administration of 0.4 mg gentamicin. The diagnosis was made by clinical and laboratory methods. The volume of liquid used in vitrectomy was recorded. Ozonized saline was to be used within the period during which the therapeutic concentration of ozone was retained. Ozonized saline in therapeutic doses is not toxic and in contrast to antibiotics, is characterized by a wide spectrum of effects. Hence, vitrectomy with ozonized normal saline is a new effective method for treating endophthalmitis."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Iuzhakov", "ForeName": "A M", "Initials": "AM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bykov", "ForeName": "V P", "Initials": "VP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ziurniaeva", "ForeName": "I D", "Initials": "ID"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gogodze", "ForeName": "M G", "Initials": "MG"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Controlled Clinical Trial", "English Abstract", "Journal Article"], "VernacularTitle": "Novye perspektivy v lechenii vnutriglazno\u012d infektsii."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Vestn Oftalmol", "NlmUniqueID": "0415216", "ISSNLinking": "0042-465X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Gentamicins"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["therapy"], "DescriptorName": "Eye Infections"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Gentamicins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Vitrectomy"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "10", "Day": "31", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "2", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "2000", "Month": "10", "Day": "31", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11055218"]}}], "PubmedBookArticle": []}